High-risk human papillomavirus in oral squamous cell carcinoma of young patients

Int J Cancer. 2012 Apr 15;130(8):1726-32. doi: 10.1002/ijc.26185. Epub 2011 Aug 5.

Abstract

The aim of this study was to investigate a possible relation between oral squamous cell carcinoma (SCC), the presence of high-risk human papillomavirus (HR-HPV) DNA and p16 expression in young patients. Paraffin-embedded tumor blocks from 47 oral SCC of young (≤40-year old) patients were evaluated. The presence of HPV DNA in tumor specimens was analyzed by polymerase chain reaction (PCR) using GP5+/GP6+ generic primers (L1 region) followed by dot blot hybridization for HPV typing. When necessary, the HPV16 positivity was confirmed by PCR HPV16 E7-specific primers. Cases involving young patients were compared with 67 oral SCC from patients ≥50-year old (controls). Demographic and clinical data were collected to analyze patient outcomes. p16(ink4) expression was evaluated by immunostaining of tissue microarrays. HPV16 was detected in 22 (19.2%) cases; 15 (68.2%) young and 7 (31.8%) control patients, a statistically significant difference (p = 0.01). In 1 (1.7%) young group specimen, HPV DNA 16 and 18 was detected. p16 expression was observed in 11 (25.6%) cases from the young group and in 11 (19.6%) controls (p = 0.48). Association between HPV and p16 was verified, and it was statistically significant (p = 0.002). The higher prevalence of high-risk HPV types, especially HPV16, may be a contributing factor to oral carcinogenesis in younger individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alphapapillomavirus / classification
  • Alphapapillomavirus / genetics
  • Alphapapillomavirus / physiology
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / therapy
  • Carcinoma, Squamous Cell / virology
  • Combined Modality Therapy
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism*
  • DNA, Viral / genetics
  • Female
  • Host-Pathogen Interactions
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / physiology
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / therapy
  • Mouth Neoplasms / virology
  • Papillomavirus Infections / metabolism*
  • Papillomavirus Infections / therapy
  • Papillomavirus Infections / virology
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Viral